Prospective, Multicentre Study to Assess Performance of the Mpact 3D Metal MonoCer Cup Implant in Primary Total Hip Replacement

Status: Active_not_recruiting
Location: See location...
Study Type: Observational
SUMMARY

This study titled Prospective, Multicentre Study to Assess Performance of the MonoCer Acetabular Cup in Primary Total Hip Replacement is a multi-centre prospective registry-nested cohort study, using AOANJRR's web-based data collection system integrated with Registry data collection, designed to assess the ten-year clinical outcome of the MonoCer Acetabular Cup in Primary Total Hip Replacement. The primary outcome measure is mortality and secondary measures are PROMs and complications.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
View:

• Patients undergoing a primary total conventional hip replacement and are suitable for cementless acetabular cup according to the indications for use (On-label use).

• Use of the Medacta Mpact 3D Metal MonoCer acetabular cup prosthesis.

• Adults aged between 18 and 75 years at the time of registration.

• Ability to give informed consent.

• Patients who are informed of the conditions of the study and are willing to participate for the length of the prescribed follow-up period.

Locations
Other Locations
Australia
Melbourne Orthopaedic Group
Melbourne
Time Frame
Start Date: 2021-01-30
Completion Date: 2032-06
Participants
Target number of participants: 280
Related Therapeutic Areas
Sponsors
Leads: Medacta International SA

This content was sourced from clinicaltrials.gov